GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CEO Sells Highlight: Keynote Systems Inc., Isis Pharmaceuticals, Coleman Cable Inc.

July 01, 2013 | About:
GuruFocus

alicet236

4 followers
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Keynote Systems Inc, Isis Pharmaceuticals, Coleman Cable Inc.

Keynote Systems, Inc. (KEYN): Chairman of the Board and CEO Umang P Gupta sold 170,000 Shares

Chairman of the Board and CEO of Keynote Systems, Inc. (KEYN) Umang P Gupta sold 170,000 shares on 06/24/2013 at an average price of $19.79. Keynote Systems, Inc. was incorporated in 1995. The Company is a global provider of Internet and mobile cloud monitoring and testing solutions. Keynote Systems, Inc. has a market cap of $364.548 million; its shares were traded at around $19.76 with a P/E ratio of 144.93 and P/S ratio of 2.94. The dividend yield of Keynote Systems, Inc. stocks is 1.27%. Keynote Systems, Inc. had an annual average earnings growth of 37.3% over the past 5 years.

Keynote Systems Inc reported net sales of $29.3 million and net earnings of $322 thousand for the Company’s 2013 second fiscal quarter.

Chairman of the Board and CEO Umang P Gupta sold 170,000 shares of KEYN stock on 06/24/2013 at the average price of 19.79. Vice President, Sales Americas John Giannitsis, VP, Int'l Sales & Support Jeffrey Kraatz, and SVP, Professional Services Donald J Aoki sold 27,511 shares of KEYN stock oin January, February and March.

Isis Pharmaceuticals (ISIS): Chairman and CEO Stanley T Crooke sold 90,000 Shares

Chairman and CEO of Isis Pharmaceuticals (ISIS) Stanley T Crooke sold 90,000 shares on 06/26/2013 at an average price of $26.73. Isis Pharmaceuticals was incorporated in California on January 10, 1989, and reorganized as a Delaware corporation in April 1991. Isis Pharmaceuticals has a market cap of $3.08 billion; its shares were traded at around $26.87 with and P/S ratio of 22.22. Isis Pharmaceuticals had an annual average earnings growth of 64.7% over the past 5 years.

With revenues of $43.4 million and net loss of $1.7 million, Isis Pharmaceuticals announced their 2013 first quarter financial results.

Chairman and CEO Stanley T Crooke sold 191,460 shares of ISIS stock in January, April, and June. SVP, Finance & CFO Elizabeth L Hougen sold 47,731 shares of ISIS stock in January, March, and April. SVP, Development Richard S Geary, Director Joseph H Wender¸ SVP, Antisense Drug Discovery Brett P Monia, Director Frederick T Muto, and SVP, Antisense Research C Frank Bennett sold 131,816 shares of ISIS stock in May and June.

Coleman Cable, Inc. (CCIX): CEO and President G Gary Yetman sold 85,236 Shares

CEO and President of Coleman Cable, Inc. (CCIX) G Gary Yetman sold 85,236 shares on 06/19/2013 at an average price of $20.11. Coleman Cable, Inc. is a designer, developer, manufacturer and supplier of electrical wire and cable products for consumer, commercial and industrial applications, with operations mainly in the United States and, to a lesser degree, Canada. Coleman Cable, Inc. has a market cap of $316.9 million; its shares were traded at around $18.11 with a P/E ratio of 12.50 and P/S ratio of 0.34. The dividend yield of Coleman Cable, Inc. stocks is 0.55%.

Coleman Cable reported their 2013 first quarter financial results. The Company reported net sales of $222.5 million and earnings per diluted share of $0.30.

CEO and President G Gary Yetman sold 376,219 shares of CCIX stock in June. Executive Vice President J Kurt Hennelly sold 67,717 shares of CCIX stock in June.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.


Rating: 2.3/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide